(C) | 1. |
¨Ì¾Ú¤¤µØ¥Á°ê¿}§¿¯f¾Ç·|¤§«Øij¡A¤U¦C¨º¨Ç¤H©|¤£¶·°µ¿}§¿¯f©M¿}§¿¯f«e´Áªº¿zÀË ?
|
A. | 28·³¤k©Ê¥h¦~¥Í²£¡AÀ¦¨à«4500¤½§J¡ABMI¬°26 Kg/¢T ¡A¦¹¥~µL¨ä¥L¿}§¿¯f·ÀI¦]¤l |
B. | 26·³¤k©Ê³Q¶EÂ_¬°¦hÅnªw§Z±_¯g¡ABMI¬°24 Kg/¢T ¡A¦¹¥~µL¨ä¥L¿}§¿¯f·ÀI¦]¤l |
C. | 32·³¨k©Ê¡A¿ì¤½«Ç¤u§@¡A°·À˵o²{HbA1C 5.8 %¡ABMI¬°23 Kg/¢T ¡A¦¹¥~µL¨ä¥L¿}§¿¯f·ÀI¦]¤l |
D. | 66·³¨k©Ê¡A¥h¦~è°h¥ð¡A°·À˵o²{HbA1C 5.6 %¡ABMI¬°23 Kg/¢T¡A¦¹¥~µL¨ä¥L¿}§¿¯f·ÀI¦]¤l |
E. | 23·³¤j¾Ç¥Í¡A¤÷¥À¬Ò¦³²Ä2«¬¿}§¿¯f¡ABMI 25 Kg/¢T ¡A¦¹¥~µL¨ä¥L¿}§¿¯f·ÀI¦]¤l |
|
(D) | 2. |
¤U¦C¨º¤@¶µ«D¶EÂ_²Ä1«¬¿}§¿¯fªº¥²n±ø¥ó¡J
|
A. | ªÅ¸¡¦å²MC-Ð`úT¿@«× < 0.5 ng/ml |
B. | ¤É¿}¯À¨ë¿E«á6¤ÀÄÁ¦å²MC-Ð`úT¿@«× < 1.8 ng/ml |
C. | ¤É¿}¯À¨ë¿E¸ÕÅç6¤À»P0¤À¦å²MC-Ð`úT¿@«×¬Û®t < 0.7 ng/ml |
D. | ¿}§¿¯f଻Ĥ¤¬r |
E. | Anti-GAD65 ¶§©Ê |
|
(C) | 3. |
¤U¦C¨º¤@ÃĪ«³Ì©ö¤Þ°_§C¦å¿}
|
A. | Metformin |
B. | Pioglitazone |
C. | Glinide Ãþ |
D. | DDP-4 inhibitor |
E. | £\- Glucosidase inhibitor |
|
(B) | 4. |
¥Ø«e»{¬°G¶¹D¤â³N¥i¨Ï¿}§¿¯f½w¸Ñ¤§¾÷Âର¤U¦C¦U¶µ¡A°£¤F
|
A. | ¶¼¹¨î |
B. | Ghrelin ¤W¤É |
C. | ¤Q¤G«ü¸z¹jµ´ |
D. | ¤U¸z¹D²üº¸»X¤W¤É |
E. | ¹¼¤¤U° |
|
(C) | 5. |
¤U¦C¨º¤@¤fªA°¦å¿}ÃĪ«¼W¥[°©ÃP¯g·ÀI ?
|
A. | Metformin |
B. | Sulfonylurea |
C. | Pioglitazone |
D. | DDP - 4 inhibitor |
E. | £\- glucosidase inhibitor |
|
(C) | 6. |
¤U¦C¨º¨Ç¤fªA°¦å¿}ÃĪ«³Q«Øij¥Î¨ÓªvÀøÀ\«á°ª¦å¿}¡A°£¤F
|
A. | Glinide |
B. | £\- Glucosidase inhibitor |
C. | Metformin |
D. | DDP - 4 inhibitor |
E. | Ultrashort acting insulin |
|
(A) | 7. |
®Ú¾Ú§Ú°ê¦¨¤H°©ÃP¯g¨¾ªv«ü¤Þ¡A¤U¦C¨º¨Ç¤H¸û¨S¦³°µ°©±K«×¿zÀˤ§¥²n©Ê
|
A. | 65·³¥H¤W¨k©Ê |
B. | ¥Òª¬¸¢¾÷¯à¤®¶i¯g¤§30·³¤k©Ê |
C. | ±w¦³Ãþ·ÀãÃö¸`ª¢¨Ï¥ÎÃþ©T¾J±wªÌ |
D. | ¥¼¨Ó10¦~¤§Æb³¡°©§é·ÀI4%¥H¤WªÌ |
E. | 65·³¥H¤W°ü¤k |
|
(B) | 8. |
29·³¤k©Ê¦³¹¬´Uä²æ««¤Î±×µø³N«á¯f¥v¡A³Ìªñ8Ó¤ë¨Ó¦³Â_Â_ÄòÄò©üºÎª¬ªp¡Aµo¥Í®É¨Ö¦³¬y¤f¤ô¡B¥|ªÏµL¤OŸ§Ý¤§±¡§Î¡A¦Y¹L¤@¨ÇªF¦è«á´N¥i«ì´_¡A½Ð°Ý±z¤U¦C±Ôz¦óªÌ¸û¥¿½T¡J
(1) ¯f¤H²Å¦X Whipple's Triad
(2) ¨x¡BµÇ¥\¯àÀˬd¬°¥²n
(3) 72¤p®Éfasting test Àˬd C- peptide¡Bglucose¡Binsulin ¬°¥²n
(4) ´ú©w¦å¤¤sulfonylurea ¿@«×¬°¥²n
(5) YÃhºÃ¯Ø®q¯À½F®É¹q¸£Â_¼hÀˬd¤j³¡¤À¥i©w¦ì
|
A. | (1)+(2)+(3) |
B. | (2)+(3)+(4) |
C. | (3)+(4)+(5) |
D. | (1)+(4)+(5) |
E. | (1)+(2)+(5) |
|
(C) | 9. |
40·³¨k©Ê¥D¶D¥þ¨°©ÀYµhµLªk¦æ¨«¨Ó¶E¡A¥L¶q¨°ª®Éµo²{¥b¦~¨Ó´î¤Ö3¤½¤À¡A¯á´ÕX - ¥úµo²{T10«e®| < «á®|¡A°©±K«× Lumbar spine T score - 2.6¡BHip T score ( ¥ª ) - 2.8¡A( ¥k ) -2.9 ¡A©â¦åÀˬd Alb 4.0 g/dl¡Bglobulin 2.5 g/dl¡BALP 150 U/L ( normal < 80 )¡BCa 9.0 mg/dl¡BP 2.0 mg/dl¡BiPTH 70 pg/ml¡Aurinalysis µLglucose¡Bamino acid¡B³J¥Õ, ¤U¦C±Ôz¦óªÌ¥¿½T
(1) ¦¹¯f¤H¬° osteoporosis ¦³ compression fracture
(2) ¦¹¯f¤H¬°°©Åè ( ¦å²G ) ¯e¯f³y¦¨osteoporosis
(3) ´ú¶q§¿ÁC¬°¥²n
(4) ´ú¶q fibroblast growth factor 23¦³§U¶EÂ_
(5) ¦¹¯f¤H¬°´c©Ê¸~½FÂಾ
|
A. | (1)+(2) |
B. | (2)+(3) |
C. | (3)+(4) |
D. | (4)+(5) |
E. | (5)+(1) |
|
(B) | 10. |
¤U¦C¦³Ãö¿}§¿¯f଻Ĥ¤¬r¤§ªvÀø¬°«ê·í
(1) ¯Ø®q¯À©y¨Ï¥Î4 - dose intensify ªvÀø
(2) ÀR¯ß¿é²Gªì©l©y§Ö³t¤j¶q¥Í²z¹ÆQ¤ô ( 10-20 ml/kg )
(3) ¹[Â÷¤l¤§¸É¥R¬°¥²n¡A°£«D¦å¹[ > 5 mM/L ¥i¼È½w
(4) «Pµo¦]¤l¥²¶·¿n·¥´M§ä¨ÃªvÀø
(5) ¤@¯ë¦å¿}¤U°«á¦å¤¤ Ketone ¦ÛµM®ø¥¢
|
A. | (1)+(2)+(3) |
B. | (2)+(3)+(4) |
C. | (3)+(4)+(5) |
D. | (4)+(5)+(1) |
E. | (5)+(1)+(2) |
|